Monday, September 15, 2014

Maker of Hepatitis C Drug Strikes Deal on Generics for Poor Countries

The agreements between Gilead Sciences and seven Indian firms seek to provide treatment to those infected but who do not live in rich countries.








from NYT > Home Page http://ift.tt/1qWhzOx

via Richard Aquilone








from WordPress http://ift.tt/1qDLQEa

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)